Ratos (RATO) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
23 Dec, 2025Executive summary
Adjusted EBITA rose 23% in Q4 and 4% for the full year, with strong cash flows and improved margins despite a cautious market.
Significant one-off items impacted comparability: SEK 1,656 million positive in Q4 2023 (Aibel goodwill reversal) and SEK 256 million negative in Q4 2024 (mainly Plantasjen restructuring, Knightec/Semcon merger, TFS).
Strategic mergers completed: Knightec and Semcon formed Knightec Group; HENT and SSEA merged into Sentia.
Plantasjen restructuring progressed as planned, with debt settlement proposals approved by courts and expected exit from reconstruction in February 2025.
Acquisition of minority shares in Presis Infra, increasing holding from 72% to 97%.
Financial highlights
Q4 net sales SEK 7,731 million, down 3% year-over-year; full-year net sales SEK 32,125 million, down 5%.
Q4 adjusted EBITA up 23% to SEK 401 million; margin improved to 9% in core business and 5.2% overall.
Full-year adjusted EBITA SEK 2,329 million, up 4%; margin at 7.2%.
Cash flow from operating activities SEK 1,403 million in Q4, SEK 3,445 million for the year; cash conversion 350% in Q4.
Board proposes dividend of SEK 1.35 per share, up from 1.25, representing 57% of adjusted net profit.
Outlook and guidance
Management expects continued margin improvement and synergies from recent mergers.
Order intake and backlog increased, positioning for continued growth despite weak markets.
Targeting adjusted EBITA of at least SEK 3 billion by 2025; Q4 2024 LTM at SEK 2,329 million.
Dividend payout ratio target 30–50% of profit after tax; proposal for 2024 at 57%.
Focus remains on consolidating the group, increasing profitability, and reducing the number of companies.
Latest events from Ratos
- Adjusted EBITA rose 17% to SEK 1,931m, with improved leverage and major restructuring.RATO
Q4 20254 Mar 2026 - Earnings and margins improved despite 9% lower sales, with strong order intake and cash flow.RATO
Q2 20243 Feb 2026 - Strong cash flow and stable earnings offset sales decline amid major restructuring.RATO
Q3 202419 Jan 2026 - Adjusted EBITA up 32% with strong order intake and Plantasjen turnaround.RATO
Q1 202528 Nov 2025 - Margin expansion and major capital gains achieved amid challenging market conditions.RATO
Q2 202516 Nov 2025 - Earnings and margins rose despite lower sales, with strong cash flow and reduced leverage.RATO
Q3 202521 Oct 2025